{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:41:08Z","timestamp":1790401268560,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81802536"],"award-info":[{"award-number":["No. 81802536"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04109-1","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T05:36:59Z","timestamp":1751953019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic dysfunction, cirrhosis, and HCV genotype 3a drive type 2 diabetes risk in chronic hepatitis C: a Southern Chinese cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Zhanyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"issue":"1732","key":"4109_CR1","doi-asserted-by":"publisher","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","volume":"372","author":"M Ringelhan","year":"2017","unstructured":"Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160274. https:\/\/doi.org\/10.1098\/rstb.2016.0274.","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"issue":"1 Suppl","key":"4109_CR2","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.jhep.2016.07.005","volume":"65","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Birerdinc A, Henry L. Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences. J Hepatol. 2016;65(1 Suppl):S109\u201319. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.005.","journal-title":"J Hepatol"},{"issue":"10207","key":"4109_CR3","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","volume":"394","author":"CW Spearman","year":"2019","unstructured":"Spearman CW, Dusheiko GM, Hellard M, Sonderup M. Hepatitis C. Lancet. 2019;394(10207):1451\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(19)32320-7.","journal-title":"Lancet."},{"issue":"2","key":"4109_CR4","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3350\/cmh.2020.0230","volume":"27","author":"O Alshuwaykh","year":"2021","unstructured":"Alshuwaykh O, Kwo PY. Current and future strategies for the treatment of chronic hepatitis C. Clin Mol Hepatol. 2021;27(2):246\u201356. https:\/\/doi.org\/10.3350\/cmh.2020.0230.","journal-title":"Clin Mol Hepatol."},{"issue":"2","key":"4109_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrgastro.2013.222","volume":"11","author":"F Negro","year":"2013","unstructured":"Negro F. Hepatitis C in 2013: HCV causes systemic disorders that can be cured. Nat Rev Gastroenterol Hepatol. 2013;11(2):77\u20138. https:\/\/doi.org\/10.1038\/nrgastro.2013.222.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"4109_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/apt.12625","volume":"39","author":"ZM Younossi","year":"2014","unstructured":"Younossi ZM, Kanwal F, Saab S, et al. The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014;39(5):518\u201331. https:\/\/doi.org\/10.1111\/apt.12625.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4109_CR7","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/infdis\/jis385","volume":"206","author":"MH Lee","year":"2012","unstructured":"Lee MH, Yang HI, Lu SN, et al. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis. 2012;206(4):469\u201377. https:\/\/doi.org\/10.1093\/infdis\/jis385.","journal-title":"J Infect Dis"},{"issue":"1","key":"4109_CR8","doi-asserted-by":"publisher","first-page":"e002145","DOI":"10.1136\/bmjdrc-2021-002145","volume":"9","author":"D Jeong","year":"2021","unstructured":"Jeong D, Karim ME, Wong S, Wilton J, Butt ZA, Binka M, Adu PA, Bartlett S, Pearce M, Clementi E, Yu A, Alvarez M, Samji H, Vel\u00e1squez Garc\u00eda HA, Abdia Y, Krajden M, Janjua NZ. Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia. BMJ Open Diabetes Res Care. 2021;9(1):e002145. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002145.","journal-title":"BMJ Open Diabetes Res Care."},{"key":"4109_CR9","doi-asserted-by":"publisher","first-page":"154802","DOI":"10.1016\/j.metabol.2021.154802","volume":"121","author":"Y Ding","year":"2021","unstructured":"Ding Y, Li G, Zhou Z, Deng T. Molecular mechanisms underlying hepatitis C virus infection-related diabetes. Metabolism. 2021;121:154802. https:\/\/doi.org\/10.1016\/j.metabol.2021.154802.","journal-title":"Metabolism."},{"issue":"6","key":"4109_CR10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/apt.12234","volume":"37","author":"ZM Younossi","year":"2013","unstructured":"Younossi ZM, Stepanova M, Nader F, et al. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther. 2013;37(6):647\u201352.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4109_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.4065\/75.4.355","volume":"75","author":"H Knobler","year":"2000","unstructured":"Knobler H, Schihmanter R, Zifroni A, et al. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc. 2000;75(4):355\u20139. https:\/\/doi.org\/10.4065\/75.4.355.","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"4109_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","volume":"49","author":"DL White","year":"2008","unstructured":"White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008;49(5):831\u201344. https:\/\/doi.org\/10.1016\/j.jhep.2008.08.006.","journal-title":"J Hepatol"},{"issue":"3","key":"4109_CR13","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","volume":"126","author":"Y Shintani","year":"2004","unstructured":"Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 2004;126(3):840\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2003.11.056.","journal-title":"Gastroenterology"},{"issue":"5","key":"4109_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jhep.2004.12.034","volume":"42","author":"K Abid","year":"2005","unstructured":"Abid K, Pazienza V, de Gottardi A, et al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol. 2005;42(5):744\u201351. https:\/\/doi.org\/10.1016\/j.jhep.2004.12.034.","journal-title":"J Hepatol"},{"issue":"4","key":"4109_CR15","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/hep.27047","volume":"60","author":"CE Ruhl","year":"2014","unstructured":"Ruhl CE, Menke A, Cowie CC, et al. Relationship of hepatitis C virus infection with diabetes in the U.S. population. Hepatology. 2014;60(4):1139\u201349. https:\/\/doi.org\/10.1002\/hep.27047.","journal-title":"Hepatology"},{"issue":"Supplement 1","key":"4109_CR16","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","volume":"41","author":"AD Association","year":"2018","unstructured":"Association AD. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142018. Diabetes care. 2018;41(Supplement 1):S13\u201327. https:\/\/doi.org\/10.2337\/dc18-S002.","journal-title":"Diabetes care"},{"issue":"13","key":"4109_CR17","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1093\/nar\/gkg500","volume":"31","author":"R Chenna","year":"2003","unstructured":"Chenna R, Sugawara H, Koike T, et al. Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res. 2003;31(13):3497\u2013500. https:\/\/doi.org\/10.1093\/nar\/gkg500.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4109_CR18","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/molbev\/msm092","volume":"24","author":"K Tamura","year":"2007","unstructured":"Tamura K, Dudley J, Nei M, et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007;24(8):1596\u20139. https:\/\/doi.org\/10.1093\/molbev\/msm092.","journal-title":"Mol Biol Evol"},{"key":"4109_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.diabres.2018.09.005","volume":"144","author":"FL Zhang","year":"2018","unstructured":"Zhang FL, Xing YQ, Guo ZN, Wu YH, Liu HY, Yang Y. Prevalence and risk factors for diabetes and impaired fasting glucose in Northeast China: Results from the 2016 China National Stroke Screening Survey. Diabetes Res Clin Pract. 2018;144:302\u201313. https:\/\/doi.org\/10.1016\/j.diabres.2018.09.005.","journal-title":"Diabetes Res Clin Pract."},{"issue":"1","key":"4109_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-39221-2","volume":"9","author":"R Wang","year":"2019","unstructured":"Wang R, Zhang P, Li Z, et al. The prevalence of pre-diabetes and diabetes and their associated factors in Northeast China: a cross-sectional study. Scientific reports. 2019;9(1):1\u20138. https:\/\/doi.org\/10.1038\/s41598-019-39221-2.","journal-title":"Scientific reports"},{"issue":"18","key":"4109_CR21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.21037\/atm.2019.09.04","volume":"7","author":"S Lu","year":"2019","unstructured":"Lu S, Bao MY, Miao SM, Zhang X, Jia QQ, Jing SQ, Shan T, Wu XH, Liu Y. Prevalence of hypertension, diabetes, and dyslipidemia, and their additive effects on myocardial infarction and stroke: a cross-sectional study in Nanjing, China. Ann Transl Med. 2019;7(18):436. https:\/\/doi.org\/10.21037\/atm.2019.09.04.","journal-title":"Ann Transl Med."},{"issue":"11","key":"4109_CR22","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.3390\/jcm10112509","volume":"10","author":"PY Su","year":"2021","unstructured":"Su PY, Chen YY, Yen HH, Huang SP, Liu IL, Zeng YH, Hsu YC, Siao FY. Strategy for the Micro-Elimination of Hepatitis C among Patients with Diabetes Mellitus-A Hospital-Based Experience. J Clin Med. 2021;10(11):2509. https:\/\/doi.org\/10.3390\/jcm10112509.","journal-title":"J Clin Med."},{"issue":"5","key":"4109_CR23","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.21276\/igbsr.2017.3-5-17","volume":"3","author":"G Azam","year":"2017","unstructured":"Azam G, Alam S, Khan AS, et al. High Prevalence of Diabetes Mellitus among Adult Patients with Viral Hepatitis C than Hepatitis B. Int J Life Sci Scienti Res. 2017;3(5):1365\u20139. https:\/\/doi.org\/10.21276\/igbsr.2017.3-5-17.","journal-title":"Int J Life Sci Scienti Res"},{"issue":"4","key":"4109_CR24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1586\/egh.11.43","volume":"5","author":"V Kaddai","year":"2011","unstructured":"Kaddai V, Negro F. Current understanding of insulin resistance in hepatitis C. Expert Rev Gastroenterol Hepatol. 2011;5(4):503\u201316. https:\/\/doi.org\/10.1586\/egh.11.43.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"11","key":"4109_CR25","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1128\/JVI.00050-12","volume":"86","author":"SK Bose","year":"2012","unstructured":"Bose SK, Shrivastava S, Meyer K, Ray RB, Ray R. Hepatitis C virus activates the mTOR\/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J Virol. 2012;86(11):6315\u201322. https:\/\/doi.org\/10.1128\/JVI.00050-12.","journal-title":"J Virol."},{"issue":"10","key":"4109_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1515\/CCLM.2009.280","volume":"47","author":"M Persico","year":"2009","unstructured":"Persico M, Russo R, Persico E, et al. SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells. Clinical chemistry and laboratory medicine. 2009;47(10):1217\u201325. https:\/\/doi.org\/10.1515\/CCLM.2009.280.","journal-title":"Clinical chemistry and laboratory medicine"},{"issue":"2","key":"4109_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.dld.2015.10.016","volume":"48","author":"E Vanni","year":"2016","unstructured":"Vanni E, Bugianesi E, Saracco G. Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality? Dig Liver Dis. 2016;48(2):105\u201311. https:\/\/doi.org\/10.1016\/j.dld.2015.10.016.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"4109_CR28","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","volume":"138","author":"KL Milner","year":"2010","unstructured":"Milner KL, van der Poorten D, Trenell M, et al. Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. Gastroenterology. 2010;138(3):932-941. e933. https:\/\/doi.org\/10.1053\/j.gastro.2009.11.050.","journal-title":"Gastroenterology"},{"issue":"3","key":"4109_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/hep.23031","volume":"50","author":"E Vanni","year":"2009","unstructured":"Vanni E, Abate ML, Gentilcore E, et al. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology. 2009;50(3):697\u2013706. https:\/\/doi.org\/10.1002\/hep.23031.","journal-title":"Hepatology"},{"issue":"4","key":"4109_CR30","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/hep.26892","volume":"59","author":"YC Hsu","year":"2014","unstructured":"Hsu YC, Lin JT, Ho HJ, et al. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology. 2014;59(4):1293\u2013302. https:\/\/doi.org\/10.1002\/hep.26892.","journal-title":"Hepatology"},{"issue":"1","key":"4109_CR31","first-page":"7","volume":"56","author":"M Pazhanivel","year":"2010","unstructured":"Pazhanivel M, Jayanthi V. Diabetes mellitus and cirrhosis liver. Minerva Gastroenterol Dietol. 2010;56(1):7\u201311.","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"2","key":"4109_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/CEJ.0000000000000038","volume":"24","author":"J Chen","year":"2015","unstructured":"Chen J, Han Y, Xu C, et al. Effect of type 2 diabetes mellitus on the risk for hepatocellular carcinoma in chronic liver diseases: a meta-analysis of cohort studies. Eur J Cancer Prev. 2015;24(2):89\u201399. https:\/\/doi.org\/10.1097\/CEJ.0000000000000038.","journal-title":"Eur J Cancer Prev"},{"issue":"9","key":"4109_CR33","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/j.1572-0241.2003.07640.x","volume":"98","author":"AJ Sanyal","year":"2003","unstructured":"Sanyal AJ, Contos MJ, Sterling RK, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome. The American journal of gastroenterology. 2003;98(9):2064\u201371. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07640.x.","journal-title":"The American journal of gastroenterology"},{"issue":"5","key":"4109_CR34","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/hep.21634","volume":"45","author":"V Pazienza","year":"2007","unstructured":"Pazienza V, Cl\u00e9ment S, Pugnale P, et al. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology. 2007;45(5):1164\u201371. https:\/\/doi.org\/10.1002\/hep.21634.","journal-title":"Hepatology"},{"issue":"1","key":"4109_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hep.22288","volume":"48","author":"A Piodi","year":"2008","unstructured":"Piodi A, Chouteau P, Lerat H, et al. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis. Hepatology. 2008;48(1):16\u201327. https:\/\/doi.org\/10.1002\/hep.22288.","journal-title":"Hepatology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04109-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04109-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04109-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T01:22:45Z","timestamp":1757208165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04109-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4109"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04109-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6332305\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was in accordance with the Declaration of Helsinki Ethical Guidelines and was approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University. All participants give informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. The study did not include any individual person\u2019s data in any form (such as identification details, images, or videos) that would require additional consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"508"}}